Congenica contributes to the BIA's Genomics Nation report
Congenica joins the BIA's report looking at the strength, breadth and opportunity of the UK genomics sector for investors, patients and the economy.
Congenica Receives CE Mark for Genomic Analysis Software
Congenica NGS data analysis software for genomic data interpretation is now CE marked under the In Vitro Diagnostics Directive.
Clinical OMICs interview with David Atkins CEO Congenica
Clinical OMICs features an interview with Congenica CEO David Atkins who talks about the genomic medicine landscape and Congenica's plans for the future.
Congenica funded to reduce fatal drug interactions by mapping genes
New software to reduce the number of adverse drug reactions is being developed thanks to a joint investment of £2 million provided by UKRI and L& G.
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia
Camtech will market, distribute, sell Congenica rapid NGS data analysis software and clinical decision support in Singapore, Malaysia, Japan, South Korea
Congenica Appoints Jayesh Pankhania as Chief Financial Officer
Digital health company Congenica, providing rapid and accurate genomic data analysis software, appoints new Chief Financial Officer, Jayesh Pankhania.
Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients
Sanford Health selects Congenica clinical decision support platform and NGS data analysis software to provide answers for undiagnosed rare disease patients
Congenica Appoints Kamraan Shariff as Chief Business Development Officer
Congenica, the company enabling rapid and accurate NGS data analysis to transform lives, today announces the appointment of Kamraan Shariff.
David Atkins joins the National Genomics Board as BIA SME representative
David Atkins, CEO of NGS data analysis software company Congenica, has joined the National Genomics Board to advise on the UK national genomics strategy.
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Congenica and Gabriel will develop a highly automated somatic cancer clinical interpretation software platform.
Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announced it has launched a local cloud solution that will enable ...
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Dr. Muthu Meyyappan appointed Chief Commercial Officer (CCO), of Congenica. Based in Boston, MA, Muthu will lead Congenica’s global market expansion.